CClinicalTrials.gg
CompletedNCT03409523Updated Jul 8, 2019

An Observational Pilot Study to Develop a Behavioral Economics Electronic Health Record Module to Guide the Care of Older Adults With Diabetes

An observational study in Diabete Mellitus, sponsored by NYU Langone Health. Completed at 1 site in United States. Open to participants aged 21 Years to 90 Years. Per ClinicalTrials.gov, last updated 2019-07-08.

Sponsored by NYU Langone Health · Observational

Study type
Observational
Model
Other
Time perspective
Prospective
Enrollment
30
Ages
21 Years to 90 Years
Sex
All
01

Study summary

This study will develop a new electronic health record module to improve guideline-compliant care of older adults with diabetes. The module will incorporate effective behavioral economics (BE) principles to improve the degree to which care of older adults is compliant with Choosing Wisely guidelines; this generally involves less aggressive targets for HbA1c, and reductions of medications other than metformin.

The implementation of the module will ultimately be triggered by medication prescribing in EPIC. The BE principles include suggesting alternatives to medications, requiring justification, setting of appropriate default order sets, and incorporation of anchoring and checklists to guide behavior. The study will involve provider workflow analysis based on observation, module user testing, and live usability testing with direct observation and semi-structure interviews.

Read the detailed description

The primary objective of this study is to develop a scalable, EHR customization toolkit that applies BE insights to promote appropriate diabetes care in older adults based on the American Geriatric Society's Choosing Wisely Guideline, as to assess the acceptability of the resulting module.

02

Conditions studied

  • Diabete Mellitus

Browse trials for

03

Who can participate

Ages eligible
21 Years to 90 Years
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

Providers in NYU outpatient primary care, geriatrics, or endocrine clinics at NYU who care for older adults with diabetes

Inclusion criteria

  • Providers in NYU outpatient primary care, geriatrics, or endocrine clinics at NYU who care for older adults with diabetes

Exclusion criteria

Exclusion Criteria:

  • None
04

Study design

Observational model
Other
Time perspective
Prospective
Enrollment
30 participants (actual)
Patient registry
No
05

What researchers measure

Primary outcomes

  1. Compliance with Choosing Wisely guidelines measured by number of reductions of medications

    The implementation of the module will ultimately be triggered by medication prescribing in EPIC.

    Time frame: 60 Months

Secondary outcomes

  1. Usability measured by module user testing with direct observation and semi structured interviews

    Time frame: 60 Months

06

Study locations

1 site
  • New York University School of Medicine
    New York, New York 10016, United States
07

References and documents

Publications

  • Belli HM, Chokshi SK, Hegde R, Troxel AB, Blecker S, Testa PA, Anderman J, Wong C, Mann DM. Implementation of a Behavioral Economics Electronic Health Record (BE-EHR) Module to Reduce Overtreatment of Diabetes in Older Adults. J Gen Intern Med. 2020 Nov;35(11):3254-3261. doi: 10.1007/s11606-020-06119-z. Epub 2020 Sep 3. PubMed 32885374 ↗
08

Registry details

Key details

Study ID
NCT03409523
Lead sponsor
NYU Langone Health
Responsible party
Sponsor
First posted
Jan 24, 2018
Start date
Jan 8, 2018
Primary completion
Jul 3, 2019
Completion
Jul 3, 2019
Last update
Jul 8, 2019

Study contacts

Andrea Troxel, MD
principal investigator · NYU Langone Health

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Jul 2019. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion